Fortea, J, Llibre-Guerra, J, O'Connor, A, Levin, J. Lessons from the Colombian kindred: rethinking Alzheimer's prevention. LANCET NEUROLOGY. 2026; 25(2)DOI:10.1016/S1474-4422(25)00481-8. PMID:41579884. IF:45.500(Q1/1D).

Pané, A, Videla, L, Calvet-Mirabent, A, Castro-Barquero, S, Viaplana, J, Vaqué-Alcázar, L, Ibarzabal, A, Rozalem-Aranha, M, Bejanin, A, Moize, V, Vidal, J, De Hollanda, A, Ortega, E, Barroeta, I, Camacho, V, Chiva-Blanch, G, Fortea, J, Jiménez, A. Cerebrospinal Fluid Fatty Acids, Hypothalamic Inflammation, and Weight Loss in Human Obesity: A Longitudinal Study. DIABETES. 2026; 75(1)DOI:10.2337/db25-0595. PMID:41247745. IF:7.500(Q1/1D).

Malé, J, Fortea, J, Rozalem-Aranha, M, Martínez-Abadías, N, Sevillano, X. Exploiting Generative Models for Downstream Classification Tasks on Latent Spaces Using 3D Brain MRI Scans: A Down Syndrome Case Study. Pattern Recognition And Image Analysis, Ibpria 2025, Pt Ii. 2026; 15938DOI:10.1007/978-3-031-99568-2_11. PMID:. IF:(Q/D).

Ulugut, H, Younes, K, Montembeault, M, Bertoux, M, Irish, M, Kumfor, F, Fumagalli, GG, Samanci, B, Illán-Gala, I, Thompson, JC, Santillo, AF, Englund, E, Waldö, ML, Riedl, L, van den Stock, J, Vandenbulcke, M, Vandenberghe, R, Laforce, R, Ducharme, S, Pressman, PS, Caramelli, P, de Souza, LC, Takada, LT, Gurvit, H, Diehl-Schmid, J, Galimberti, D, Pasquier, F, Weintraub, S, Miller, BL, Sturm, VE, Whitwell, JL, Boeve, B, Rohrer, JD, Piguet, O, Gorno-Tempini, ML, Josephs, KA, Snowden, J, Rowe, JB, Warren, JD, Rankin, KP, Pijnenburg, YAL. Clinical recognition of frontotemporal dementia with right temporal predominance: a consensus statement from the International Working Group. Communications Medicine. 2025; 5(1)DOI:10.1038/s43856-025-01252-4. PMID:41387629. IF:(Q/D).

Rubio-Guerra, S, Sala, I, Sánchez-Saudinos, MB, Videla, L, Bejanin, A, Estanga, A, Ecay-Torres, M, de Luis, CL, Rami, L, Tort-Merino, A, Castellví, M, Pozueta, A, García-Martínez, M, Gomez-Andrés, D, Lage, C, Lopez-García, S, Sánchez-Juan, P, Balasa, M, Llado, A, Altuna, M, Tainta, M, Arranz, J, Zhu, NL, Alcolea, D, Lleo, A, Fortea, J, Rodríguez, ER, Sánchez-Valle, R, Martínez-Lage, P, Illán-Gala, I. Amyloid-negative neuropsychological norms: Added value in the era of biomarkers and disease-modifying therapies. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2025; 17(4)DOI:10.1002/dad2.70223. PMID:41383878. IF:(Q/D).

Rubio-Guerra, S, Sánchez-Saudinos, MB, Sala, I, Videla, L, Bejanin, A, Estanga, A, Ecay-Torres, M, de Luis, CL, Rami, L, Tort-Merino, A, Castellví, M, Pozueta, A, García-Martínez, M, Gomez-Andrés, D, Lage, C, Lopez-García, S, Sánchez-Juan, P, Balasa, M, Llado, A, Altuna, M, Tainta, M, Arranz, J, Zhu, NL, Alcolea, D, Lleo, A, Fortea, J, Rodríguez, ER, Sánchez-Valle, R, Martínez-Lage, P, Illán-Gala, I. Development of amyloid-negative neuropsychological norms using GAMLSS. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2025; 17(4)DOI:10.1002/dad2.70224. PMID:41383879. IF:(Q/D).

Andersen, OM, de Waal, MWJ, Monti, G, Tesi, N, Jensen, AMG, De Geus, C, van Spaendonk, R, Vogel, M, Ahmad, S, Amin, N, Amouyel, P, Beecham, GW, Bellenguez, C, Berr, C, Bis, JC, Boland, A, Bossù, P, Bouwman, F, Bras, J, Charbonnier, C, Clarimon, J, Cruchaga, C, Daniele, A, Dartigues, JF, Debette, S, Deleuze, JF, Denning, N, Destefano, AL, Dols-Icardo, O, van Duijn, CM, Farrer, LA, Fernández, MV, van der Flier, WM, Fox, NC, Galimberti, D, Genin, E, Gille, JJP, Grenier-Boley, B, Grozeva, D, Guen, YL, Guerreiro, R, Haines, JL, Holmes, C, Hummerich, H, Ikram, MA, Ikram, MK, Kawalia, A, Kraaij, R, Lambert, JC, Lathrop, M, Lemstra, AW, Lleo, A, Myers, RM, Mannens, MMAM, Marshall, R, Martin, ER, Masullo, C, Mayeux, R, Mead, S, Mecocci, P, Meggy, A, Mol, MO, Nacmias, B, Naj, AC, Napolioni, V, Cochran, JN, Nicolas, G, Pasquier, F, Pastor, P, Pericak-Vance, MA, Pijnenburg, YAL, Piras, F, Quenez, O, Ramirez, A, Raybould, R, Redon, R, Reinders, MJT, Richard, AC, Riedel-Heller, SG, Rivadeneira, F, van Rooij, JGJ, Rousseau, S, Ryan, NS, Sanchez-Juan, P, Schellenberg, GD, Scheltens, P, Schott, JM, Seshadri, S, Sie, D, Sims, R, Sistermans, EA, Sorbi, S, van Swieten, JC, Tijms, B, Uitterlinden, AG, Visser, PJ, Wagner, M, Wallon, D, Wang, LS, Williams, J, Yokoyama, JS, Zarea, A, van der Lee, SJ, Olsen, JG, Hulsman, M, Holstege, H. Domain mapping of disease mutations reveals pathogenic SORL1 variants in Alzheimer's disease. Molecular Neurodegeneration. 2025; 20(1)DOI:10.1186/s13024-025-00907-z. PMID:41327266. IF:17.500(Q1/1D).

Barba, L, Bellomo, G, Alcolea, D, Wojdala, AL, Gaetani, L, Fortea, J, Abu-Rumeileh, S, Lleó, A, Parnetti, L, Belbin, O, Otto, M, Oeckl, P. Serum level changes of the synaptic marker beta-synuclein in Alzheimer's disease continuum and other dementias. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2025; 96(12)DOI:10.1136/jnnp-2025-336189. PMID:40571405. IF:7.500(Q1/1D).